Eliza Hall

Type: Person
Name: Eliza Hall
First reported Sep 30 2014 - Updated 23 hours ago - 1 reports

New bowel cancer weapon

A PROMISING breakthrough by Melbourne medical researchers reveals that more than 80 per cent of bowel cancers could be treated with existing drugs. The Walter and Eliza Hall team found that a specific class of drugs not only stops tumours growing in pre-clinical ... [Published NEWS.com.au - Sep 30 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

FLOY CAROL ALENT

in Ann Arbor following a battle with cancer. She was born on September 7, 1937, the daughter of the late Alexander Milford and Ethel Eliza (Hall) Stirrett.Floy graduated from Bad Axe Public Schools in 1955. She married Eugene Alent on July 27, 1963 in ... [Published Huron County View - Sep 04 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Floy Carol Alent

, 76, of Bad Axe passed away Aug. 30, 2014, in Ann Arbor following a battle with cancer. She was born Sept. 7, 1937, daughter of the late Alexander Milford and Ethel Eliza (Hall) Stirrett. She married Eugene Alent July 27, 1963, in St. Mary’s Catholic ... [Published Huron Daily Tribune - Sep 03 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Ice bucket challenge in Bowral: Photos and video

ICE and coffee have been used in Bowral to fight back against motor neurone disease (MND). ICE and coffee have been used in Bowral to fight back against motor neurone disease (MND). 2 Park Road store owner Melinda Lamond braved the ice bucket challenge ... [Published Southern Highland News - Sep 03 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Séralini study is given new life, but where's the new data?

By David Vaux , Walter and Eliza Hall InstituteA controversial 2012 paper on the effects of genetically modified (GM) maize and the herbicide glyphosate on tumour growth in rats – a paper later retracted by the journal – has been republished , with ... [Published GMO Pundit a.k.a. David Tribe - Jun 25 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Alchemia Announces First Patient Enrolled in Investigator-Led Phase II Trial of HA-Irinotecan and Erbitux ("CHIME" Trial)

BRISBANE, AUSTRALIA--(Marketwired - Jun 20, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that the first patient has been enrolled into the new clinical trial of HA-Irinotecan and Erbitux® (cetuximab); ... [Published Marketwire - Breaking News Releases - Jun 20 2014]
First reported Apr 21 2014 - Updated Apr 22 2014 - 1 reports

Dr. Bruce Stillman CSHL President wins 2014 Herbert Tabor Research Award

Dr. Bruce Stillman, President of Cold Spring Harbor Laboratory (CSHL),is the 2014 winner of the HerbertTabor Research Award from the AmericanSociety for Biochemistry and Molecular Biology (ASBMB). The award isgiven for excellence in biological chemistry ... [Published BioPortfolio - Apr 21 2014]

More Content

All (7) | News (5) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
New bowel cancer weapon [Published NEWS.com.au - Sep 30 2014]
FLOY CAROL ALENT [Published Huron County View - Sep 04 2014]
Floy Carol Alent [Published Huron Daily Tribune - Sep 03 2014]
Ice bucket challenge in Bowral: Photos and video [Published Southern Highland News - Sep 03 2014]
Séralini study is given new life, but where's t... [Published GMO Pundit a.k.a. David Tribe - Jun 25 2014]
Alchemia Announces First Patient Enrolled in In... [Published Marketwire - Breaking News Releases - Jun 20 2014]
Dr. Bruce Stillman CSHL President wins 2014 Her... [Published BioPortfolio - Apr 21 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Séralini study is given new life, but where's t... [Published GMO Pundit a.k.a. David Tribe - Jun 25 2014]
By David Vaux , Walter and Eliza Hall InstituteA controversial 2012 paper on the effects of genetically modified (GM) maize and the herbicide glyphosate on tumour growth in rats – a paper later retracted by the journal – has been republished , with ...
Alchemia Announces First Patient Enrolled in In... [Published Marketwire - Breaking News Releases - Jun 20 2014]
BRISBANE, AUSTRALIA--(Marketwired - Jun 20, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that the first patient has been enrolled into the new clinical trial of HA-Irinotecan and Erbitux® (cetuximab); ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.